Boehringer Ingelheim Presents First Data for Tiotropium in Adolescents with ... Sacramento Bee This dose-ranging study evaluated 105 patients 12 to 17 years of age with moderate, persistent asthma on medium dose inhaled corticosteroids (ICS) with or without long-acting beta-agonist (LABA) or leukotriene receptor antagonists (LTRA). |
